1. Home
  2. GNLX vs PDEX Comparison

GNLX vs PDEX Comparison

Compare GNLX & PDEX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GNLX
  • PDEX
  • Stock Information
  • Founded
  • GNLX 2001
  • PDEX 1978
  • Country
  • GNLX United States
  • PDEX United States
  • Employees
  • GNLX N/A
  • PDEX N/A
  • Industry
  • GNLX Biotechnology: Pharmaceutical Preparations
  • PDEX Medical/Dental Instruments
  • Sector
  • GNLX Health Care
  • PDEX Health Care
  • Exchange
  • GNLX Nasdaq
  • PDEX Nasdaq
  • Market Cap
  • GNLX 128.0M
  • PDEX 152.3M
  • IPO Year
  • GNLX 2023
  • PDEX N/A
  • Fundamental
  • Price
  • GNLX $3.91
  • PDEX $32.69
  • Analyst Decision
  • GNLX Strong Buy
  • PDEX Strong Buy
  • Analyst Count
  • GNLX 4
  • PDEX 1
  • Target Price
  • GNLX $17.75
  • PDEX $56.00
  • AVG Volume (30 Days)
  • GNLX 151.7K
  • PDEX 35.9K
  • Earning Date
  • GNLX 11-13-2025
  • PDEX 10-30-2025
  • Dividend Yield
  • GNLX N/A
  • PDEX N/A
  • EPS Growth
  • GNLX N/A
  • PDEX 345.00
  • EPS
  • GNLX N/A
  • PDEX 2.67
  • Revenue
  • GNLX N/A
  • PDEX $66,593,000.00
  • Revenue This Year
  • GNLX N/A
  • PDEX $7.22
  • Revenue Next Year
  • GNLX N/A
  • PDEX N/A
  • P/E Ratio
  • GNLX N/A
  • PDEX $12.45
  • Revenue Growth
  • GNLX N/A
  • PDEX 23.68
  • 52 Week Low
  • GNLX $1.95
  • PDEX $23.68
  • 52 Week High
  • GNLX $5.89
  • PDEX $70.26
  • Technical
  • Relative Strength Index (RSI)
  • GNLX 59.55
  • PDEX 30.34
  • Support Level
  • GNLX $3.76
  • PDEX $31.72
  • Resistance Level
  • GNLX $3.61
  • PDEX $47.81
  • Average True Range (ATR)
  • GNLX 0.25
  • PDEX 2.08
  • MACD
  • GNLX 0.05
  • PDEX -1.00
  • Stochastic Oscillator
  • GNLX 67.03
  • PDEX 6.03

About GNLX Genelux Corporation

Genelux Corp is a clinical-stage biopharmaceutical company. The company focuses on developing next-generation oncolytic viral immunotherapies for patients suffering from aggressive or difficult-to-treat solid tumor types. Its pipeline products include Olvi-Vec (olvimulogene nanivacirepvec), Lung, and Pancreatic Cancer.

About PDEX Pro-Dex Inc.

Pro-Dex Inc is engaged in the design, development, and manufacture of autoclavable, battery-powered and electric, multi-function surgical drivers and shavers used in the orthopedic, thoracic, and craniomaxillofacial (CMF) markets. The company also designs and manufactures multi-axis motion control systems used in factory automation and scientific research markets. Majority of the company's revenue is derived from designing, developing, and manufacturing surgical devices for the medical device and dental industries.

Share on Social Networks: